Seres Therapeutics
MCRB
MCRB
79 hedge funds and large institutions have $344M invested in Seres Therapeutics in 2017 Q1 according to their latest regulatory filings, with 9 funds opening new positions, 29 increasing their positions, 25 reducing their positions, and 11 closing their positions.
New
Increased
Maintained
Reduced
Closed
Holders
79
Holders Change
-10
Holders Change %
-11.24%
% of All Funds
1.97%
Holding in Top 10
1
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.02%
New
9
Increased
29
Reduced
25
Closed
11
Calls
$1.14M
Puts
$298K
Net Calls
+$843K
Net Calls Change
+$1.1M
Top Buyers
| 1 |
1
BlackRock
New York
|
$19.2M |
| 2 |
AIM
2
ARK Investment Management
St. Petersburg,
Florida
|
$7.1M |
| 3 |
3
Vanguard Group
Malvern,
Pennsylvania
|
$17.6M |
| 4 |
SIM
4
Spark Investment Management
New York
|
$613K |
| 5 |
5
JPMorgan Chase & Co
New York
|
$4.17M |
